New pill could tame stubborn high blood pressure
NCT ID NCT07142356
First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 32 times
Summary
This study tests a new drug called RTN-001 for people whose high blood pressure remains high even when taking two or more standard medications. About 280 adults will take either RTN-001 or a placebo daily for 12 weeks. The main goal is to see if the drug lowers blood pressure more than a placebo and to check for any side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UNCONTROLLED HYPERTENSION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Retension Clincal Site
RECRUITINGPlano, Texas, 75024, United States
Contact Email: •••••@•••••
-
Retension Clincial Site
RECRUITINGBoston, Massachusetts, 02131, United States
Contact Email: •••••@•••••
-
Retension Clinical Site
RECRUITINGSan Jose, California, 95128, United States
Contact Email: •••••@•••••
-
Retension Clinical Site
RECRUITINGWest Hills, California, 91307, United States
Contact Email: •••••@•••••
-
Retension Clinical Site
RECRUITINGWaterbury, Connecticut, 06708, United States
Contact Email: •••••@•••••
-
Retension Clinical Site
RECRUITINGOrlando, Florida, 32801, United States
Contact Email: •••••@•••••
-
Retension Clinical Site
RECRUITINGPort Orange, Florida, 32127, United States
Contact Email: •••••@•••••
-
Retension Clinical Site
RECRUITINGTampa, Florida, 33606, United States
Contact Email: •••••@•••••
-
Retension Clinical Site
RECRUITINGLawrenceville, Georgia, 30044, United States
Contact Email: •••••@•••••
-
Retension Clinical Site
RECRUITINGLas Vegas, Nevada, 89109, United States
Contact Email: •••••@•••••
-
Retension Clinical Site
RECRUITINGLas Vegas, Nevada, 89121, United States
Contact Email: •••••@•••••
-
Retension Clinical Site
RECRUITINGAsheboro, North Carolina, 27203, United States
Contact Email: •••••@•••••
-
Retension Clinical Site
RECRUITINGCharlotte, North Carolina, 28210, United States
Contact Email: •••••@•••••
-
Retension Clinical Site
RECRUITINGMonroe, North Carolina, 28112, United States
Contact Email: •••••@•••••
-
Retension Clinical Site
RECRUITINGCincinnati, Ohio, 45245, United States
Contact Email: •••••@•••••
-
Retension Clinical Site
RECRUITINGCharleston, South Carolina, 29407, United States
Contact Email: •••••@•••••
-
Retension Clinical Site
RECRUITINGDallas, Texas, 75230, United States
Contact Email: •••••@•••••
-
Retension Clinical Site
RECRUITINGSan Antonio, Texas, 78215, United States
Contact Email: •••••@•••••
-
Retension Clinical Site
RECRUITINGVienna, Virginia, 22182, United States
Contact Email: •••••@•••••
-
Rretension clinical site
RECRUITINGBellaire, Texas, 77401, United States
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.